Read Kim Lawton’s interview with Gregory Stock, CEO of Signum Biosciences and director of the Medicine, Technology, and Society Program at the UCLA School of Medicine: Q: What kind of research are you doing? A: Here at Signum we are … More →

August 17, 2007